These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32367340)

  • 81. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels.
    Moutzouri E; Liberopoulos EN; Florentin M; Liamis G; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):13-8. PubMed ID: 22539817
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).
    Ballantyne CM; Weiss R; Moccetti T; Vogt A; Eber B; Sosef F; Duffield E;
    Am J Cardiol; 2007 Mar; 99(5):673-80. PubMed ID: 17317370
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma: An ALTAIR Trial Report.
    Sugizaki Y; Otake H; Kawamori H; Toba T; Nagano Y; Tsukiyama Y; Yanaka KI; Yamamoto H; Nagasawa A; Onishi H; Takeshige R; Nakano S; Matsuoka Y; Tanimura K; Takahashi Y; Fukuyama Y; Shinke T; Ishida T; Hirata KI
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1452-1454. PubMed ID: 32199850
    [No Abstract]   [Full Text] [Related]  

  • 87. Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy　- An Observational Pharmacy Claims Database Study.
    Umeda T; Hayashi A; Fujimoto G; Piao Y; Matsui N; Tokita S
    Circ J; 2019 Jul; 83(8):1689-1697. PubMed ID: 31281135
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Effects of Lipid-Lowering Therapy on Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio: An HIJ-PROPER Sub-Analysis.
    Arashi H; Yamaguchi J; Kawada-Watanabe E; Otsuki H; Sekiguchi H; Ogawa H; Hagiwara N
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):548-555. PubMed ID: 32567339
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of evolocumab therapy on coronary fibrous cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome.
    Yano H; Horinaka S; Ishimitsu T
    J Cardiol; 2020 Mar; 75(3):289-295. PubMed ID: 31495548
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Fixed-dose combination of rosuvastatin and ezetimibe].
    Šatný M
    Vnitr Lek; 2020; 66(8):513-517. PubMed ID: 33740852
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
    Rollefstad S; Ikdahl E; Hisdal J; Olsen IC; Holme I; Hammer HB; Smerud KT; Kitas GD; Pedersen TR; Kvien TK; Semb AG
    Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of high-dose strong statin for preventing periprocedural ischemic complications of carotid artery stenting.
    Shinozaki N; Murakami T; Ohno Y; Nakano M; Fujii T; Nakazawa G; Yoshimachi F; Ikari Y
    Heart Vessels; 2020 Jun; 35(6):762-768. PubMed ID: 31925501
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
    Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
    Mani V; Woodward M; Samber D; Bucerius J; Tawakol A; Kallend D; Rudd JH; Abt M; Fayad ZA
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):571-82. PubMed ID: 24458953
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors.
    Brahmachari B; Chatterjee S
    Indian J Pharmacol; 2015; 47(5):563-4. PubMed ID: 26600650
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study.
    Godino C; Pavon AG; Mangieri A; Salerno A; Cera M; Monello A; Chieffo A; Magni V; Cappelletti A; Margonato A; Colombo A
    Clin Cardiol; 2017 Aug; 40(8):605-611. PubMed ID: 28422300
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome.
    Sexton TR; Wallace EL; Macaulay TE; Charnigo RJ; Evangelista V; Campbell CL; Bailey AL; Smyth SS
    J Thromb Thrombolysis; 2015 Feb; 39(2):186-95. PubMed ID: 25307674
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells.
    Woźniak E; Broncel M; Niedzielski M; Woźniak A; Gorzelak-Pabiś P
    PLoS One; 2023; 18(2):e0280741. PubMed ID: 36753488
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers.
    Kim H; Choi HY; Kim YH; Bae KS; Jung J; Son H; Lim HS
    Drug Des Devel Ther; 2018; 12():815-821. PubMed ID: 29692602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.